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Abstract
The mechanisms, by which the P2 receptor agonists adenosine 5P-triphosphate (ATP) and uridine 5P-triphosphate (UTP)
evoke an increase in the free cytosolic calcium concentration ([Ca2]i) and in intracellular pH (pHi), have been investigated in
Ehrlich ascites tumor cells. The increase in [Ca2]i evoked by ATP or UTP is abolished after depletion of intracellular Ca2
stores with thapsigargin in Ca2-free medium, and is inhibited by U73122, an inhibitor of phospholipase C (PLC), indicating
that the increase in [Ca2]i is primarily due to release from intracellular, Ins(1,4,5)P3-sensitive Ca2 stores. ATP also activates
a capacitative Ca2-entry pathway. ATP as well as UTP evokes a biphasic change in pHi, consisting of an initial acidification
followed by alkalinization. Suramin and 4,4P-diisothiocyano-2,2P-stilbene-disulfonic acid (DIDS) inhibit the biphasic change
in pHi, apparently by acting as antagonists at P2 receptors. The alkalinization evoked by the P2 receptor agonists is found to
be due to activation of a 5P-(N-ethyl-N-isopropyl)amiloride (EIPA)-sensitive Na/H exchanger. ATP and UTP elicit rapid
cell shrinkage, presumably due to activation of Ca2 sensitive K and Cl3 efflux pathways. Preventing cell shrinkage, either
by incubating the cells at high extracellular K concentration, or by adding the K-channel blocker, charybdotoxin, does not
affect the increase in [Ca2]i, but abolishes the activation of the Na/H exchanger, indicating that activation of the Na/H
exchanger is secondary to the Ca2-induced cell shrinkage. 0005-2736 / 98 / $ ^ see front matter ß 1998 Elsevier Science
B.V. All rights reserved.
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1. Introduction
Extracellular adenosine 5P-triphosphate (ATP) is
involved in the regulation of numerous biological
processes, including neurotransmission, transepithe-
lial chloride secretion, cell proliferation and apopto-
sis [1^5]. Furthermore, recent reports have assigned
important roles for both ATP and uridine 5P-triphos-
phate (UTP) as autocrine messengers in a diverse
range of cell types under various conditions of stress,
including mechanical and osmotic stresses [6^10]. Ex-
tracellular ATP exerts its e¡ects via two major recep-
tor families, the P2X receptors, which are ligand
gated ion channels, and the P2Y receptors, which
are G protein-coupled [2,11]. It is well established
that in most tissues studied, P2Y receptor stimula-
tion leads to the activation of an inositol phospholi-
pid-speci¢c phospholipase C (PLC), leading to the
formation of diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (Ins(1,4,5)P3) [1,2,11]. Ins-
(1,4,5)P3 elicits release of Ca2 from Ins(1,4,5)P3-sen-
sitive stores, which is in many cells accompanied by
Ca2 in£ux ascribed to the capacitative Ca2 entry
(CCE) pathway [1,2,13^16]. Moreover, P2 receptor
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stimulation has been shown to activate multiple pro-
tein kinases, including protein kinase C (PKC), and
the mitogen activated protein (MAP) kinase cascades
[1,10,17], as well as several di¡erent phospholipases
[1,12,18,19].
In Ehrlich ascites tumor cells, micromolar concen-
trations of ATP cause PtdIns(4,5)P2 hydrolysis, in-
crease cellular levels of Ins(1,4,5)P3 and phosphatidic
acid (PA), and elicit an increase in [Ca2]i [21,22].
We have recently reported that the Ehrlich cells pos-
sess P2Y1- and P2Y2 receptors, but probably not
P2X receptors [6]. ATP acting via P2Y receptors
has been found to activate several types of ion chan-
nels, including Ca2-dependent K channels in Ehr-
lich cells [6,23] and in many other cell types
[13,24,25], as well as both Ca2-dependent [24,25]
and -independent [26] Cl3 channels. Although simul-
taneous activation of K and Cl3 channels is ex-
pected to lead to cell shrinkage, the e¡ect of ATP
on cell volume in Ehrlich cells is unclear, i.e., no
e¡ect [21] or cell shrinkage [22] has been reported
previously. It may also be noted that acceleration
of the regulatory volume decrease (RVD) response
after addition of ATP has recently been described
in Ehrlich cells [23].
In several cell types including Ehrlich cells, ATP
has been shown to exert a biphasic e¡ect on pHi,
consisting of an initial acidi¢cation, followed by al-
kalinization to above the initial steady state pHi [27^
30]. This is not universally observed, thus, in various
other cells, only acidi¢cation [31], only alkalinization
[32], or no e¡ect on pHi [33] is seen upon addition of
ATP. In rat cardiac myocytes [29,34] and rabbit os-
teoclasts [31], ATP-induced acidi¢cation is suggested
to re£ect activation of a Cl3/HCO33 exchanger. In
Ehrlich cells, the nature of the initial acidi¢cation
has not been studied, whereas the subsequent alka-
linization has previously been shown to re£ect the
activation of a Na/H exchanger [27]. The signal
transduction pathway involved was not elucidated,
although a partial dependence on PKC was sug-
gested.
In some cell types, activation of a Na/H ex-
changer by other Ca2 mobilizing agonists has been
suggested to be a consequence of Ca2-induced cell
shrinkage [35^38]. However, for the ATP-induced
activation of the Na/H exchanger, this possibility
has not previously been investigated.
The homeostasis of [Ca2]i, pHi, and cell volume is
tightly interrelated, and minor modulations of these
parameters may be part of the signaling cascades
triggering such diverse events as apoptosis or prolif-
eration (see e.g. Ref. [39]). In the present study, we
investigate the consequences of P2 receptor stimula-
tion in Ehrlich cells with respect to [Ca2]i, pHi, and
cell volume. The aim of the study was to elucidate
the mechanisms of, and causal relationship between,
these changes, in order to gain new insight into how
P2 receptor agonists may exert their diverse cellular
functions.
A part of this investigation has previously been
presented in abstract form [40].
2. Materials and methods
2.1. Cell suspensions and incubation media
The Ehrlich ascites tumor cells (hyperdiploid
strain) were maintained in NMRI mice by weekly
intraperitoneal transplantation. The cells in the as-
cites £uid were harvested in standard incubation me-
dium containing heparin (2.5 IU/ml), washed 2^3
times by centrifugation (700Ug, 45 s) in standard
medium without heparin, resuspended at a cytocrit
of 4% and preincubated for 15^30 min before initia-
tion of experiments (for details, see Ref. [41]). The
standard incubation medium was of the following
composition (mM): 150 Na, 5 K, 154 Cl3,
1 Mg2, 1 Ca2, 1 SO234 , 1 PO
33
4 , 3,3,3-(N-mor-
pholino)propanesulfonic acid (MOPS), 3,3-N-tris-
(hydroxymethyl)methyl-2-aminoethanesulfonic acid
(TES); 3,3-N-(2-hydroxyethyl)piperazine-NP-2-etha-
nesulfonic acid (Hepes); pH was adjusted to 7.4
with NaOH. In Ca2-free medium, addition of
Ca2 was omitted and ethylene glycol-bis(L-amino-
ethylether)-N,N,NP,NP-tetraacetic acid (EGTA,
2 mM) was added. In ‘high [K]’-media, 48 mM
KCl was substituted for 48 mM NaCl, to yield a
total [K] of 53 mM. In KCl media, NaCl was sub-
stituted by KCl in equimolar amounts. In these me-
dia, pHo was adjusted with KOH. In HCO33 media,
25 mM NaHCO3 was substituted for 25 mM NaCl.
In experiments performed at pHo 8.2, MOPS, TES
and Hepes were replaced by 5 mM N,N-bis(2-hy-
droxymethyl)glycine (Bicine) and 5 mM N-tris(hy-
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droxymethyl)methylglycine (Tricine). Unless other-
wise indicated, experiments were carried out at 37‡C.
2.2. Measurement of pHi
Loading of the Ehrlich cells with 2P,7P-bis-(2-car-
boxyethyl)-5,6-carboxy£uorescein, tetraacetoxymeth-
yl ester (BCECF-AM) and measurement of pHi was
performed essentially as previously described [42].
Brie£y, cell suspensions were incubated with
BCECF-AM (3.6 WM) at 37‡C for 30 min, followed
by two washes in standard medium containing bo-
vine serum albumin, fraction V (BSA) (1 mg/ml) and
resuspension in this medium at a cytocrit of 8%.
Following dilution of the BCECF-loaded cell suspen-
sion to a cytocrit of 0.3%, pHi was estimated using a
Perkin^Elmer LS-5 luminescence spectrophotometer.
Emission was measured at 525 nm after excitation at
445 nm and 495 nm (band width 5 nm). Extracellular
£uorescence (comprising 10^20% of total £uores-
cence) was subtracted prior to calculation of the
445 nm/495 nm ratio. Linear in situ calibration of
the BCECF £uorescence signal to pHi was per-
formed after each experiment, according to the niger-
icin method [43]. Three to four di¡erent values of
pHo were used to construct a linear calibration curve
(rs 0.98). The compounds used (EIPA, thapsigargin,
DIDS, suramin) were found to have no, or only in-
signi¢cant, intrinsic £uorescence at the settings used.
2.3. Measurement of [Ca2+]i
[Ca2]i was assessed in cell suspensions using the
Ca2-sensitive £uorescent probe fura-2, according to
[44]. Brie£y, cell suspensions were incubated at 37‡C
for 20 min with fura-2-AM (2 WM), washed once in
standard medium containing 0.2% BSA, and once in
the experimental medium, and resuspended in this
medium at a cytocrit of 5%. Following dilution of
the fura-2 loaded cell suspensions to a cytocrit of
0.5%, [Ca2]i was estimated using a Perkin^Elmer
LS-5 luminescence spectrophotometer. The excita-
tion wavelengths were 340 nm and 380 nm, emission
was measured at 510 nm (band width 5 nm). Extra-
cellular £uorescence (15^25% of total £uorescence)
was subtracted from the intensities measured after
excitation at each wavelength before calculation of
the 340 nm/380 nm ratio. The fura-2 signal was cali-
brated in vitro according to Ref. [45], as previously
described for Ehrlich cells in Ref. [44]. A new cali-
bration was performed after any alterations in the
experimental setup.
2.4. Measurement of cell volume
Cell volume was measured by electronic cell sizing
using a Coulter Multisizer II (Coulter, Luton, Beds,
UK), after dilution of the cells to a cytocrit of
0.016% in the standard medium. The tube ori¢ce
was 100 Wm. Mean cell volume was calculated as
the median of the cell volume distribution curves
after calibration with latex beads (diameter 14.1
Wm, Coulter). Media used for volume measurements
were ¢ltered (Millipore ¢lters, 0.45 Wm) prior to use.
2.5. Reagents
Unless otherwise indicated, all reagents were ana-
lytical grade and obtained from Sigma (St. Louis,
MO, USA). 5P-(N-ethyl-N-isopropyl)amiloride, hy-
drochloride (EIPA), BCECF-AM, fura-2-AM and
fura-2-P (pentapotassium salt) were purchased from
Molecular Probes (Leiden, Netherlands). Thapsigar-
gin and charybdotoxin were from Alamone Labs,
Jerusalem, Israel. Heparin was from LÖvens Kemiske
(Ballerup, Denmark). 1-(6-(17b-3-methoxyestra-
1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-di-
one (U73122) and 1-(6-(17b-3-metoxyestra-1,3,5(10)-
trien-17-yl)amino)hexyl)-pyrrolidine-dione (U73343)
were from Biomol Research Laboratories (Plymouth,
PA, USA), and were dissolved at 10 mM in chloro-
form. Suramin was from Research Biochemicals
(MA, USA), and was dissolved at 100 mM in double
distilled water and kept refrigerated until use. Ad-
enosine, ATP and UTP were prepared as 10.7 mM
stock solutions in standard medium containing 0.1
mM EGTA (free concentration of nucleotides calcu-
lated using EQCal (Biotool, 1988) and assuming the
same a⁄nity for Ca2 and Mg2 for all nucleotides.
Charybdotoxin (5 WM) was dissolved in standard
medium containing 0.1% BSA. 4,4P-Diisothiocyano-
2,2P-stilbene-disulfonic acid (DIDS) was dissolved at
10.7 mM in double distilled water. Nigericin (1 mg/
ml) and thapsigargin (1 mM) were dissolved in 96%
ethanol. BCECF-AM (1.2 mM) and fura-2-AM
(1 mM) were dissolved in anhydrous dimethylsulfox-
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ide (DMSO). Unless otherwise noted, all these
reagents were kept at 320‡C until use. The maximal
¢nal vehicle concentrations were: DMSO 0.5%,
chloroform 0.1%, ethanol 0.2%. At these concentra-
tions, the experiments were una¡ected by these com-
pounds (data not shown).
2.6. Data analysis and statistics
The rate of change in pHi was calculated as the
slope of the linear ¢t of the measurements obtained
0^60 s after the maximal acidi¢cation, during which
time the change in pHi can be considered linear
(rs 0.98). EC50 values for the e¡ects of ATP and
UTP on pHi were obtained from ¢ts to the Michae-
lis^Menten equation. EC50 values for inhibition of
the ATP- and UTP-induced changes in pHi by
DIDS (Fig. 4) were calculated using the equation
y = ymaxW(131/(1+EC50/[DIDS])), where ymax is the in-
itial acidi¢cation, or the rate of alkalinization, re-
spectively, and y is the corresponding value at any
given concentration of DIDS ([DIDS]).
Results are presented as means þ S.E.M. with the
number of independent experiments in parentheses.
Single experiments shown are representative of at
least three individual experiments. Signi¢cance was
tested using a Student’s t-test (level of signi¢cance
P6 0.05).
3. Results
3.1. Sources of the increase in [Ca2+]i induced by the
P2 receptor agonists
As seen in Fig. 1, stimulation of Ehrlich ascites
tumor cells suspended in standard experimental me-
dium (1 mM Ca2) with ATP (15 WM) elicited a
rapid increase in the free cytosolic calcium concen-
tration ([Ca2]i), followed by a lag phase of elevated
[Ca2]i. The mean increase in [Ca2]i was 202 þ
52 nM (n = 12). When ATP (15 WM) was added to
cells preincubated in Ca2-free medium (2 mM
EGTA), the increase in [Ca2]i was signi¢cantly re-
duced, to 123 þ 56 nM (P6 0.02, n = 13). As seen,
UTP (15 WM) also elicited a transient increase in
[Ca2]i. The mean UTP-induced increase in [Ca2]i
was 207 þ 21 nM (n = 4) in standard experimental
medium, and 143 þ 44 nM (n = 3) in Ca2 free me-
dium, not signi¢cantly lower than that seen in stand-
ard medium.
The role of phospholipase C (PLC) in the signaling
events leading to the increase in [Ca2]i induced by
P2 receptor stimulation was studied using the PLC
inhibitor U73122, and the inactive analog, U73343
[46,47]. After preincubation of the cells in standard
medium with the inactive analog, U73343 (10 WM),
the increase in [Ca2]i induced by 15 WM ATP was
242 þ 19 nM (n = 4), not signi¢cantly di¡erent from
the increase seen after addition of 15 WM ATP to
Fig. 1. Contributions of Ca2 release and Ca2 in£ux to the in-
crease in [Ca2]i elicited by ATP and UTP. [Ca2]i was mea-
sured spectrophotometrically in fura-2-loaded Ehrlich cells sus-
pended at a cytocrit of 0.5% in standard medium (A, C, E, F)
or in Ca2-free medium containing 2 mM EGTA (B and D).
(A, B) ATP (15 WM) was added at the time indicated by arrow
(n = 12 in standard medium, n = 13 in Ca2-free medium). (C,
D) UTP (15 WM) was added at the time indicated by arrow
(n = 4 in standard medium, n = 3 in Ca2-free medium). (E, F)
The PLC-inhibitor, U73122 (10 WM, n = 4, P6 0.001), or the in-
active analogue, U73343 (10 WM, n = 4), was added 2 min prior
to stimulation of the cells with ATP. Similar results were ob-
tained with UTP (n = 2^3, data not shown).
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control cells. In contrast, after preincubation with
U73122 (10 WM), the increase in [Ca2]i induced by
15 WM ATP was reduced by 82%, to 43 þ 19 nM
(n = 4), which was signi¢cantly lower than that ob-
served in cells preincubated with U73343 (P6 0.001)
and that observed in control cells (P6 0.001) (Fig.
1E,F). A similar pattern was observed following
stimulation with 15 WM UTP (n = 3, data not
shown).
Thapsigargin (TG) is a sesquiterpene lactone well
known to inhibit the sarcoplasmic/endoplasmic retic-
ulum Ca2-ATPase (SERCA) responsible for the re-
uptake of Ca2 into the Ins(1,4,5)P3 sensitive stores.
Thapsigargin application therefore results in Ca2
depletion of these stores [48]. As seen in Fig. 2A,
in Ca2-free medium (2 mM EGTA), addition of
TG (500 nM) leads to a slow increase in [Ca2]i,
representing discharge of Ins(1,4,5)P3-sensitive
stores, followed by a decrease, which is due to the
subsequent extrusion of Ca2 across the plasma
membrane. Upon a subsequent addition of ATP,
the increase in [Ca2]i was essentially abolished, re-
inforcing the notion that ATP-induced Ca2 release
occurs primarily from Ins(1,4,5)P3-sensitive stores.
In contrast to the transient increase in [Ca2]i seen
in Ca2-free medium (2 mM EGTA), treatment of
cells suspended in standard medium (1 mM Ca2)
with TG (500 nM) resulted in a sustained elevation
of [Ca2]i (Fig. 2B,C). This has been described in
many cell types, including Ehrlich cells, and re£ects
activation of Ca2 in£ux from the extracellular me-
dium as a consequence of the depletion of Ins(1,4,5)-
P3-sensitive stores by TG [49,50]. The e¡ect of a
subsequent stimulation with ATP (1 WM) was found
to be dependent on the time elapsed between TG
treatment and stimulation. Thus, if ATP was added
shortly (3^4 min, Fig. 2B) after TG treatment, a
transient increase in [Ca2]i was seen, which was pos-
sibly due to release of Ca2 from stores which had
not yet been depleted, and which was followed by a
rapid decrease below the level prior to addition of
ATP (Fig. 2B). In contrast, if a longer time (6 min
and above) had elapsed after TG treatment, presum-
ably resulting in e¡ective depletion of the Ins(1,4,5)-
P3-sensitive Ca2 stores, a subsequent addition of
ATP lead to a transient decrease in [Ca2]i (Fig.
2C). The mechanisms involved in the ATP-evoked
decrease in [Ca2]i were not further investigated
here, but several possibilities can be envisaged (see
Section 4).
3.2. E¡ect of ATP and UTP on pHi
Addition of ATP (15 WM) elicited a transient intra-
cellular acidi¢cation, followed by alkalinization. The
initial ATP-induced acidi¢cation and the subsequent
alkalinization were inhibited by 68% and 73%, re-
spectively, in the presence of suramin (100 WM), a
non-speci¢c inhibitor of P2-purinoceptors [51] (Fig.
3, Table 1). As seen in Table 1, the changes in pHi
induced by UTP were of similar magnitudes as those
induced by ATP, but were more potently inhibited
by suramin. Thus, suramin inhibited the initial UTP-
Fig. 2. E¡ects of ATP on [Ca2]i in thapsigargin-treated cells.
[Ca2]i was measured spectrophotometrically in fura-2-loaded
Ehrlich cells suspended at a cytocrit of 0.5% in Ca2 free me-
dium containing 2 mM EGTA (A) or in standard experimental
medium (B and C). (A) Thapsigargin (TG, 500 nM) was added
as indicated by the arrow, followed by addition of 15 WM ATP
and 15 WM UTP, as indicated. The experiment is representative
of three independent experiments. (B, C) TG (500 nM) was
added as indicated by the arrow, followed by addition of ATP
at the concentrations indicated. The experiments shown are rep-
resentative of seven (B) and three (C) independent experiments.
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induced acidi¢cation by 84%, and the subsequent
alkalinization by 94%, respectively. In contrast, the
changes in pHi induced by a higher dose of ATP (100
WM) were una¡ected by suramin (Table 1), indicating
that suramin is a competitive inhibitor of P2Y recep-
tors in Ehrlich cells. Furthermore, although other
mechanisms cannot be excluded, these results suggest
that the overall a⁄nity for ATP at P2Y receptors in
Ehrlich cells is higher than for UTP.
In some cells, the initial, ATP-induced acidi¢ca-
tion has been suggested to re£ect the activation of
a Cl3/HCO33 exchanger [29]. In Ehrlich cells, the
ATP-induced acidi¢cation was transient and of sim-
ilar magnitude in control cells and in the presence of
EIPA to inhibit the Na/H exchanger (n = 4, data
not shown). Moreover, this acidi¢cation was not
augmented under conditions at which the activity
of the Cl3/HCO33 exchanger is known to be readily
detectable in these cells (pHo 8.2, 25 mM HCO33 , see
Ref. [54]) (n = 2, data not shown). These ¢ndings
argue against the notion that P2 receptor agonists
Fig. 3. ATP and UTP elicit a suramin-sensitive, biphasic change
in pHi. pHi was measured spectrophotometrically in BCECF-
loaded Ehrlich cells suspended at a cytocrit of 0.3% in the
standard experimental medium. 15 WM ATP (A) or UTP (B)
was added at the time indicated by arrow, in control cells
(open circles) or in the presence of suramin (100 WM), added
2 min prior to addition of the agonists. The traces shown are
representative of 3^5 experiments for each condition, and are
summarized in Table 1.
Table 1
E¡ect of suramin on the ATP- and UTP-evoked changes in pHi
ATP, 15 WM ATP, 100 WM UTP, 15 WM
Initial pHi
decreasea
Rate of pHi
increaseb
Initial
pHi decrease
Rate of pHi
increase
Initial pHi
decrease
Rate of pHi
increase
Control 0.056 þ 0.005 (4) 0.14 þ 0.017 (4) 0.070 þ 0.005 (4) 0.10 þ 0.013 (4) 0.056 þ 0.0045 (5) 0.130 þ 0.005 (5)
Suramin, 100 WM 0.018 þ 0.0091 (3) 0.04 þ 0.017 (3) 0.070 þ 0.019 (3) 0.10 þ 0.026 (3) 0.009 þ 0.0002 (3) 0.008 þ 0.0037 (3)
Percent inhibition 68 73 0 0 84 94
The experimental protocol was as described in the legend to Fig. 3. The ATP- and UTP-induced acidi¢cation was calculated as the to-
tal decrease in pHi following addition of the agonist. The ATP- and UTP-induced alkalinization was calculated as the slope of the lin-
ear ¢t of the measurements obtained 0^60 s after the maximal acidi¢cation, during which time the change in pHi can be considered
linear (rs 0.98). The number of experiments is given in parenthesis.
aIn pH units.
bIn pH units min31.
Fig. 4. Inhibition of ATP- and UTP-induced changes in pHi by
DIDS. pHi was measured spectrophotometrically in BCECF-
loaded Ehrlich cells suspended at a cytocrit of 0.3% in the
standard experimental medium. DIDS (10^300 WM) was added
1 min prior to addition of 15 WM ATP (A and B) or UTP
(C and D). EC50 values are calculated using the equation
y = ymaxW(131/(1+EC50/[DIDS])), where ymax is the initial acidi¢-
cation (A and C) or the rate of alkalinization (B and D), re-
spectively, and y is the corresponding value at any given con-
centration of DIDS ([DIDS]). The ¢gures shown are based on
3^5 independent experiments at each concentration.
BBAMEM 77441 9-9-98
S.F. Pedersen et al. / Biochimica et Biophysica Acta 1374 (1998) 94^106 99
activate a Cl3/HCO33 exchanger in these cells, and
indicate that other mechanisms are involved in the
ATP-induced acidi¢cation (see Section 4).
The stilbene derivative 4,4P-diisothiocyano-2,2P-
stilbene-disulfonic acid (DIDS) is commonly used
as an inhibitor of Cl3/HCO33 exchangers [52]. How-
ever, DIDS has been reported to be a competitive
antagonist at P2 receptors [53], and hence un¢t for
evaluating possible e¡ects of P2 agonists on Cl3/
HCO33 exchange. As seen in Fig. 4, DIDS inhibited
the initial acidi¢cation following addition of ATP or
UTP (15 WM), as well as the subsequent alkaliniza-
tion, in a concentration-dependent manner. The
EC50 values for the DIDS-induced inhibition of
ATP-induced acidi¢cation and alkalinization were
estimated at 43 and 44 WM, respectively (Fig.
4A,B), while the corresponding values for the UTP-
induced responses were 23 and 28 WM, respectively
(Fig. 4C,D). These latter results cannot be explained
by an inhibitory e¡ect of DIDS on a Cl3/HCO33
exchanger, but are a strong indication that this com-
pound is an inhibitor of P2Y receptors, or at least of
an early step in the signal transduction cascade. Fur-
thermore, they con¢rm the above observation that
UTP has a lower overall a⁄nity at P2 receptors in
these cells than does ATP. The concentration^re-
sponse relationships of the ATP- and UTP-induced
initial acidi¢cation are shown in Fig. 5. As seen, the
acidi¢cation induced by both P2 receptor agonists is
well ¢tted by simple Michaelis^Menten kinetics, and
the responses were similar, although, at any given
concentration, the acidi¢cation induced by UTP
appears to be slightly lower than that induced by
ATP.Fig. 5. Concentration-dependency of the ATP- and UTP-in-
duced acidi¢cation. pHi was measured spectrophotometrically
in BCECF-loaded Ehrlich cells suspended at a cytocrit of 0.3%
in the standard experimental medium. The graphs show the to-
tal intracellular acidi¢cation induced by various concentrations
(1^100 WM) of ATP (A) or UTP (B). The acidi¢cation was cal-
culated as the di¡erence between the steady state pHi prior to,
and the minimum pHi reached after addition of ATP or UTP
(see Fig. 3). The EC50 value and the maximal acidi¢cation in-
duced were estimated by ¢tting the data to the Michaelis^Ment-
en equation. The following values were obtained. ATP: EC50
3.8 WM, maximal acidi¢cation 0.07 pH units; UTP: EC50 2.6
WM, maximal acidi¢cation 0.06 pH units. The graphs shown
are based on data from 3^5 independent experiments for each
condition.
Fig. 6. Activation of an EIPA-sensitive Na/H exchanger by
ATP. pHi was measured spectrophotometrically in BCECF-
loaded Ehrlich cells suspended at a cytocrit of 0.3% in the
standard experimental medium (see Section 2). (A) ATP (15
WM) was added at the time indicated by the arrow, in control
experiments (open circles), or in the presence of EIPA (10 WM,
closed circles). The experiment shown is representative of four
(control) and three (EIPA) experiments, respectively. (B) Con-
centration-dependency of the ATP-induced activation of the
Na/H exchanger. The experimental protocol was as in A.
The ATP concentration required for half-maximal e¡ect was
estimated at about 3 WM (n = 3^4 at each concentration).
Similar experiments with UTP resulted in an estimated half-
maximal concentration of about 5.5 WM (n = 3^5 at each con-
centration).
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3.3. ATP and UTP activate an EIPA-sensitive
Na+/H+ exchanger
Fig. 6A shows that the P2 receptor-mediated intra-
cellular alkalinization was abolished in the presence
of EIPA (10 WM), suggesting that it represents acti-
vation of the NHE-1 or NHE-2 isoform of Na/H
exchangers (see Ref. [35]). This extends the previous
observation [27] of activation of amiloride-sensitive
Na/H exchange by ATP in these cells. Fig. 6B
shows the rate of intracellular alkalinization, re£ect-
ing the activation of the Na/H exchanger, as a
function of the concentration of ATP. As seen, the
rate of intracellular alkalinization increased with in-
creasing ATP concentration up to about 15 WM
ATP, with a half-maximal e¡ect estimated at about
3 WM. At ATP concentrations above 15 WM, a slight
decrease in the rate of alkalinization was seen, which
was not further investigated in the present study.
Similar results were found for UTP; however, the
UTP concentration required for half-maximal e¡ect
was somewhat higher, estimated at about 5.5 WM
(n = 3^4 at each concentration, data not shown).
3.4. Role of cell shrinkage in the P2 receptor-mediated
activation of Na+/H+ exchange
In Ca2-free medium (2 mM EGTA) and in the
presence of TG, the ATP-induced, biphasic change in
pHi was completely abolished (n = 3, data not
shown). This indicates that the increase in [Ca2]i,
which is also abolished under these conditions (Fig.
2A), is required at some step in the signal transduc-
tion mechanism leading to activation of the Na/H
exchanger. Activation of K and Cl3 e¥ux by other
Ca2 mobilizing agonists has previously been shown
to elicit cell shrinkage in these cells [55]. As seen in
Fig. 7, stimulation of Ehrlich cells in standard me-
dium with ATP (15 WM) induced a rapid cell shrink-
age (10 þ 3% of the original cell volume within 30 s
(n = 5)), followed by rapid volume recovery. Similar
results were obtained with UTP (15 WM, n = 2, data
not shown).
Cell shrinkage is a potent stimulus for activation
of the Na/H exchanger in Ehrlich cells [38,42] as
well as in many other cell types [35]. We therefore
Fig. 7. E¡ect of ATP on cell volume. Cell volume was mea-
sured by electronic cell sizing using a Coulter Multisizer II after
dilution of the cells to a cytocrit of 0.016% in the standard me-
dium. ATP (15 WM) was added at the time indicated by the ar-
row. The median cell volume was calculated as the median of
the cell volume distribution curves after calibration with latex
beads. The ATP-induced cell shrinkage was 10 þ 3% (n = 5) of
the normal cell volume (measured at the time of maximal cell
shrinkage, approximately 30 s after stimulation). Similar results
were obtained with UTP (15 WM, n = 2).
Fig. 8. E¡ect of preventing cell shrinkage on the ATP-evoked
changes in [Ca2]i and pHi. (A) [Ca2]i was measured spectro-
photometrically in fura-2-loaded Ehrlich cells suspended at a
cytocrit of 0.5% in ‘high K’ medium (53 mM K, see Section
2). ATP (15 WM) was added as indicated by the arrow. The in-
crease in [Ca2]i is not signi¢cantly inhibited in cells suspended
in ‘high K’ medium as compared to cells suspended in stand-
ard experimental medium (n = 3 and 12, respectively) (B) Cellu-
lar pH (pHi) was measured spectrophotometrically in BCECF-
loaded Ehrlich cells suspended at a cytocrit of 0.3% in the
standard experimental medium. ATP (15 WM) was added as in-
dicated by the arrow (n = 3). It has previously been shown that
cell shrinkage induced by Ca2 mobilizing agonists is prevented
in the ‘high K’ medium [56].
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investigated the role of cell shrinkage in the P2 re-
ceptor-mediated activation of the exchanger, taking
advantage of the fact that K loss, and concomitant
cell shrinkage have previously been shown to be ex-
actly prevented at 53 mM extracellular K in these
cells [56]. As seen in Fig. 8A, when the Ehrlich cells
were incubated at this [K]o, the increase in [Ca2]i
induced by stimulation with ATP (15 WM) was
231 þ 10 nM (n = 3), which is not signi¢cantly di¡er-
ent from that seen in standard medium (compare
Fig. 1A, 202 þ 52 nM, n = 12). Similar results were
obtained with UTP (n = 3, data not shown). The
lack of e¡ect of high [K]o on the ATP-induced in-
crease in [Ca2]i was to be expected, since the in-
crease in [Ca2]i was primarily due to release of
Ca2 from intracellular stores, and hence was little
a¡ected by the altered driving force for Ca2 in£ux
(Figs. 1 and 2). In contrast, under these conditions,
stimulation with ATP (15 WM) did not activate the
Na/H exchanger. In the ‘high [K]’ medium, it can
be calculated that the driving force for the Na/H
exchanger is reduced by about 16%. In order to rule
out the possibility that the inhibition of the exchang-
er under these conditions re£ects the reduction in
driving force, an alternative approach was employed.
In Ehrlich cells, the blocker of Ca2-activated K
channels, charybdotoxin (ChTX, 100 nM), com-
pletely inhibits ATP-induced K e¥ux [23], and fur-
thermore inhibits K loss (and hence, cell shrinkage)
induced by Ca2 mobilizing agonists by about 70%
[57]. The ATP-induced increase in [Ca2]i was not
inhibited by ChTX [6]; however, in the presence of
ChTX (100 nM), the ATP-induced activation of the
Na/H exchanger was strongly attenuated (data not
shown). Taken together, these observations are in
agreement with the hypothesis that the activation
of the Na/H exchanger by P2 receptor agonists
is secondary to the cell shrinkage induced by an in-
crease in [Ca2]i.
Finally, it should be noted that pHi is una¡ected
by adenosine and isoproterenol, indicating that acti-
vation of the exchanger does not re£ect extracellular
breakdown of ATP and stimulation of P1 receptors
(data not shown). This is supported by the ¢nding
that activation of the exchanger is inhibited by sur-
amin, which is not an inhibitor at P1 receptors (see
e.g. Ref. [22]), and is a particularly important point
in transformed cells such as Ehrlich cells, which ex-
hibit unusually high ecto-ATPase and ectonucleoti-
dase activity [1,20].
4. Discussion
4.1. Mechanisms of the P2 receptor mediated increase
in [Ca2+]i
The present study investigates the cellular events
initiated via P2 receptor activation in Ehrlich ascites
tumor cells. Stimulation with ATP (15 WM) or UTP
(15 WM) elicits an increase in [Ca2]i, of which only
the ATP-induced increase is signi¢cantly reduced in
Ca2-free medium. The increase in [Ca2]i induced
by both P2Y receptor agonists is mainly mediated
via activation of a PLC, followed by release of
Ca2 from Ins(1,4,5)P3-sensitive stores. Similar re-
sults have been reported in many other cell types
[1,25,59]. The activation of PLC by P2Y receptor
activation has been reported to be either pertussis
toxin-insensitive (Gq mediated), or at least partly
pertussis toxin-sensitive (mediated via LQ subunits
from Gi proteins) (see Refs. [11,58]). In contrast, in
rat cardiac myocytes the increase in [Ca2]i induced
by ATP is suggested to be secondary to intracellular
acidi¢cation [60]. This can be excluded in the present
study, since the ATP-induced acidi¢cation is abol-
ished when the increase in [Ca2]i is prevented (Fig.
2A).
Regarding the nature of the ATP-activated Ca2
in£ux pathway, it is interesting to note that while
about 40% of the ATP-induced increase in [Ca2]i
under control conditions is due to Ca2 in£ux (com-
pare Fig. 1A and B), the residual increase in [Ca2]i
in cells treated with the PLC inhibitor, U73122, is
less than 20% of that observed under control condi-
tions. Thus, most of the Ca2 in£ux appears to be
dependent on an increase in Ins(1,4,5)P3, suggesting
that depletion of Ins(1,4,5)P3-sensitive Ca2 stores by
ATP stimulates capacitative Ca2 entry (CCE) in
these cells, in agreement with ¢ndings from many
other cell types [12^15]. The nature of the CCE path-
way(s) is essentially obscure, although this phenom-
enon is usually observed following stimulation with
TG [49,62,63,66].
The origin of the residual increase in [Ca2]i seen
in the presence of U73122 was not further investi-
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gated. However, it may be noted that this could be a
nonspeci¢c e¡ect of this U73122, because it has been
reported that this compound may in itself cause an
increase in [Ca2]i, via e¡ects not related to inhibi-
tion of PLC [61].
When the Ehrlich cells are preincubated with TG
long enough (about 6 min) to presumably completely
deplete Ins(1,4,5)P3-sensitive Ca2 stores and fully
activate CCE, ATP does not elicit a further increase
in [Ca2]i, even in the presence of extracellular Ca2
(Fig. 2C). This supports the notion that the main
Ca2 entry pathway is CCE, which is already max-
imally activated under these conditions, and is also in
congruence with our recent ¢nding that P2X recep-
tors are not present in these cells [6].
A notable ¢nding is the decrease in [Ca2]i in TG-
treated cells upon a subsequent stimulation with
ATP (Fig. 2). This is only seen in the presence of
extracellular Ca2, indicating that in these cells,
ATP may inhibit the Ca2 in£ux already activated
by TG. In CFPAC-1 epithelial cells, stimulation with
ATP also induced a decrease in [Ca2]i ; however, in
those cells, this e¡ect was shown to be due to stim-
ulation of Ca2 e¥ux [64]. The mechanism involved
in the apparent inhibition of CCE by ATP under
these conditions awaits further investigation, but sev-
eral putative schemes can be proposed. It could be a
consequence of ATP-induced cell shrinkage, since
cell shrinkage has been found to inhibit Ca2 entry
in Ehrlich cells [38]. This would require that K and/
or Cl3 currents are still activated by ATP in the
absence of a bulk increase in [Ca2]i. In this regard
it may be noted that Ca2-independent activation of
Cl3 currents by ATP has been reported [26]. The
apparent inhibition of Ca2 entry by ATP could
also re£ect phosphorylation-dependent events, since
CCE is found to be inactivated by PKC in many cell
types [15,63,65]. TG does not elicit a measurable in-
crease in the cellular level of Ins(1,4,5)P3 (see Ref.
[49]), whereas ATP is known to increase Ins(1,4,5)P3
levels in Ehrlich cells, and thus is expected to activate
a PKC [19]. Consequently, it may be speculated that
in TG treated cells stimulation with ATP, in concert
with the already elevated [Ca2]i, leads to a substan-
tial activation of PKC, resulting in inhibition of CCE.
Whatever the mechanism, inhibition of CCE by ATP
could provide an important feedback regulation of
[Ca2]i following stimulation with this agonist.
4.2. ATP and UTP elicit a biphasic change in pHi,
which is inhibited by suramin and DIDS
As reported previously, ATP and UTP both elicit
a biphasic change in pHi in Ehrlich cells [27]. Sura-
min is the most widely used P2 receptor antagonist,
although it has a range of other biological activities
[see [22,67]]. This drug inhibits the biphasic e¡ect on
pHi elicited by a moderate (15 WM), but not by a
higher (100 WM), concentration of ATP, suggesting
that suramin is a competitive inhibitor of P2Y recep-
tors in Ehrlich cells. Changes in pHi induced by UTP
are inhibited to a greater extent than those induced
by ATP (Fig. 3, Table 1). Similarly, the increase in
[Ca2]i elicited by a low concentration (10 WM) of
ATP in these cells is abolished by suramin [6]. Our
results are in agreement with a recent study in which
suramin is reported to be a predominantly compet-
itive inhibitor at P2X and P2Y receptors [51]. DIDS,
a stilbene derivative commonly used as an inhibitor
of anion transport [52], was also found to inhibit the
ATP- and UTP-induced changes in pHi. This is in
agreement with ¢ndings in renal pigment epithelial
cell [68], as well as with a recent report indicating
that DIDS is a competitive inhibitor at P2Y recep-
tors in the rat vas deferens [53].
Similar to suramin, DIDS is a more potent inhib-
itor of UTP-mediated (EC50 about 25 WM) than
ATP-mediated (EC50 about 44 WM) e¡ects on pHi.
This is in good agreement with the higher EC50 value
for the UTP-evoked, compared to the ATP-evoked,
increase in [Ca2]i, and is also consistent with our
recent report of two main receptor populations in
Ehrlich cells: a P2Y1 receptor activated preferentially
by ATP and 2-methylthioadenosine 5P-triphosphate
(2-MeSATP), and a P2Y2 receptor activated prefer-
entially by UTP and ATP [6].
As discussed in Section 3.2, the initial acidi¢cation
induced by P2 receptor stimulation is unlikely to be
due to activation of a Cl3/HCO33 exchanger. Other
possible mechanisms which could account for a cy-
toplasmic acidi¢cation following stimulation with
Ca2 mobilizing agonists such as ATP and UTP in-
clude: (i) competition for intracellular bu¡ers by H
and Ca2, (ii) H countertransport by mitochon-
drial-, endoplasmic reticulum- and plasma membrane
Ca2-ATPases [69], (iii) a Ca2-mediated increase in
metabolic acid production, and (iv) hyperpolariza-
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tion-induced H in£ux across the plasma membrane
[70]. The latter possibility is in agreement with our
¢nding that the activation of K channels by ATP
results in a signi¢cant hyperpolarization in these cells
[6].
4.3. Activation of a Na+/H+ exchanger by ATP is
secondary to Ca2+-induced cell shrinkage
In the present study, P2 receptor activation is
found to elicit transient cell shrinkage under isotonic
conditions, at least partly due to the activation of a
ChTX-sensitive, Ca2 dependent K current by ATP
[6,23]. The nature of the Cl3 current which must also
be activated by ATP in order to elicit net loss of KCl
and concomitant cell shrinkage has not been directly
demonstrated (for a discussion, see Ref. [6]). How-
ever, substantial whole cell Cl3 currents are known
to be activated after small increases in [Ca2]i in
these cells [71].
Activation of the ubiquitous NHE-1 isoform of
the Na/H exchangers by osmotic cell shrinkage
and by growth factors are known to share several
similarities, although both pathways are incompletely
understood [35]. The present study demonstrates that
P2 receptor-mediated activation of the exchanger can
be inhibited in the presence of a maximal increase in
[Ca2]i, by preventing the agonist-induced cell
shrinkage (Fig. 8). Thus, it is suggested that activa-
tion of the Na/H exchanger is preferentially medi-
ated by the ATP-induced cell shrinkage, and that the
role of Ca2 in the activation process is to elicit cell
shrinkage. Similar results were obtained after stimu-
lation with bradykinin in transformed NIH-3T3 ¢-
broblasts [37], with carbachol in rat acinar cells [36],
and with thrombin and bradykinin in Ehrlich cells
[38], suggesting that it may be a general mechanism
involved in the activation of the exchanger by many
types of growth factors, mitogens and neurotransmit-
ters. It may be noted that the present ¢ndings are
compatible with the previously proposed partial role
for PKC in the ATP-induced activation of the ex-
changer in these cells [27]. Thus, in Ehrlich cells,
PKC is activated within 1 min of osmotic cell shrink-
age [72], and shrinkage-induced activation of the ex-
changer appears to be at least partly dependent on a
PKC isoform [42]. In other cell types, the activation
of a Na/H exchanger by ATP has been reported to
be either Ca2- and PKC-dependent, and pertussis
toxin-insensitive [28]; PKC dependent [30] ; Ca2-
and PKC-independent [34]; or PKC-independent,
partially Ca2-dependent, and pertussis toxin-sensi-
tive [32].
4.4. Functional signi¢cance of P2 receptors in
Ehrlich cells
We have recently reported that in Ehrlich cells,
ATP is released by mechanical stress [6], and accel-
erates the RVD process [23], suggesting that nucleo-
tides may play a role as autocrine messengers during
RVD in these cells.
The present study suggests an important role for
cell volume in the signal transduction events between
ATP-induced changes in [Ca2]i and activation of a
Na/H exchanger and concomitant elevation of
pHi. Cell shrinkage is known to inhibit Ca2 entry
in Ehrlich cells [38], and in HT29 cells [73]. Thus, it
may be speculated that the ATP-evoked cell shrink-
age and intracellular alkalinization could play impor-
tant roles in the feedback regulation of Ca2 signal-
ing events. Moreover, in rat pancreatic acinar cells
[74], alkaline pHi reduces agonist-induced release
of [Ca2]i. Finally, given the numerous cellular
processes known to be regulated by pHi (see e.g.
Ref. [75]), the ATP-evoked intracellular alkaliniza-
tion is likely to be important in mediating cellular
e¡ects evoked following stimulation of P2 recep-
tors.
In conclusion, in Ehrlich cells, ATP and UTP ac-
tivate release of Ca2 from Ins(1,4,5)P3 sensitive
stores, and ATP also activates Ca2 entry from the
extracellular medium, by a mechanism which is
mainly dependent on PLC. In contrast, in TG-
treated cells in Ca2-containing medium, ATP
evokes a transient decrease in [Ca2]i, possibly due
to inhibition of CCE. ATP and UTP elicit an initial
decrease in pHi, followed by an increase, both of
which are inhibited by suramin and by DIDS. The
P2 receptor-mediated increase in pHi is due to acti-
vation of a Na/H exchanger, by a mechanism
which appears to be mainly secondary to the ATP-
induced cell shrinkage elicited by activation of Ca2-
dependent K and Cl3 channels.
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